Design of a population-based longitudinal cohort study of SARS-CoV-2 incidence and prevalence among adults in the San Francisco Bay Area

[1]  Ellicott C. Matthay,et al.  Excess mortality among Latino people in California during the COVID-19 pandemic , 2021, SSM - population health.

[2]  C. Bern,et al.  Variation in SARS-CoV-2 Infection Risk and Socioeconomic Disadvantage Among a Mayan-Latinx Population in Oakland, California , 2021, JAMA network open.

[3]  Jessica A Hinman,et al.  Association Between Income Inequality and County-Level COVID-19 Cases and Deaths in the US , 2021, JAMA network open.

[4]  B. Cowling,et al.  Diagnostic performance of different sampling approaches for SARS-CoV-2 RT-PCR testing: a systematic review and meta-analysis , 2021, The Lancet Infectious Diseases.

[5]  L. Morris,et al.  Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351) , 2021, The New England journal of medicine.

[6]  R. Westergaard,et al.  Rapid Spread of SARS-CoV-2 in a State Prison After Introduction by Newly Transferred Incarcerated Persons — Wisconsin, August 14–October 22, 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[7]  K. Grumbach,et al.  Association of Race/Ethnicity With Likeliness of COVID-19 Vaccine Uptake Among Health Workers and the General Population in the San Francisco Bay Area , 2021, JAMA internal medicine.

[8]  B. Mustanski,et al.  Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure , 2021, JCI insight.

[9]  T. Pastinen,et al.  Antibody Responses after a Single Dose of SARS-CoV-2 mRNA Vaccine , 2021, The New England journal of medicine.

[10]  R. Peeling,et al.  Scaling up COVID-19 rapid antigen tests: promises and challenges , 2021, The Lancet Infectious Diseases.

[11]  N. Dendukuri,et al.  Comparison of Saliva and Nasopharyngeal Swab Nucleic Acid Amplification Testing for Detection of SARS-CoV-2: A Systematic Review and Meta-analysis. , 2021, JAMA internal medicine.

[12]  L. Fleisher,et al.  Rates of COVID-19 Among Residents and Staff Members in Nursing Homes — United States, May 25–November 22, 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[13]  D. Swerdlow,et al.  Estimation of US SARS-CoV-2 Infections, Symptomatic Infections, Hospitalizations, and Deaths Using Seroprevalence Surveys , 2021, JAMA network open.

[14]  M. Killerby,et al.  Performance of an Antigen-Based Test for Asymptomatic and Symptomatic SARS-CoV-2 Testing at Two University Campuses — Wisconsin, September–October 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[15]  Marcio K. Oikawa,et al.  Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic , 2020, Science.

[16]  G. Kang,et al.  Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India , 2020, The Lancet Global Health.

[17]  M. Peluso,et al.  Universal Polymerase Chain Reaction and Antibody Testing Demonstrate Little to No Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 in a Rural Community , 2020, Open forum infectious diseases.

[18]  Shaghayegh Haghjooy Javanmard,et al.  SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study , 2020, The Lancet Infectious Diseases.

[19]  R. Tibshirani,et al.  Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome , 2020, Science Immunology.

[20]  R. Hasnain-Wynia,et al.  Disproportionate Incidence of COVID-19 Infection, Hospitalizations, and Deaths Among Persons Identifying as Hispanic or Latino — Denver, Colorado March–October 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[21]  Ellsworth M. Campbell,et al.  Multidisciplinary Community-Based Investigation of a COVID-19 Outbreak Among Marshallese and Hispanic/Latino Communities — Benton and Washington Counties, Arkansas, March–June 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[22]  Kimberly D. Moss,et al.  Serologic Testing of US Blood Donations to Identify Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Reactive Antibodies: December 2019–January 2020 , 2020, Clinical Infectious Diseases.

[23]  A. Jha,et al.  Association of race, ethnicity, and community-level factors with COVID-19 cases and deaths across U.S. counties , 2020, Healthcare.

[24]  B. Mustanski,et al.  Patterns and persistence of SARS-CoV-2 IgG antibodies in Chicago to monitor COVID-19 exposure , 2020, medRxiv.

[25]  M. Lipsitch,et al.  How to detect and reduce potential sources of biases in epidemiologic studies of SARS-CoV-2 , 2020 .

[26]  H. Neuhauser,et al.  Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[27]  Meral Yüce,et al.  COVID-19 diagnosis —A review of current methods , 2020, Biosensors and Bioelectronics.

[28]  R. Paulino-Ramírez,et al.  Seroprevalence of Specific Antibodies against SARS-CoV-2 from Hotspot Communities in the Dominican Republic , 2020, The American journal of tropical medicine and hygiene.

[29]  P. Hsueh,et al.  Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review , 2020, International Journal of Infectious Diseases.

[30]  James T. Webber,et al.  Rapid deployment of SARS-CoV-2 testing: The CLIAHUB , 2020, PLoS pathogens.

[31]  G. Chertow,et al.  Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study , 2020, The Lancet.

[32]  Gregory M. Goldgof,et al.  SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood , 2020, Nature Communications.

[33]  G. Pialoux,et al.  Evaluation of performance of two SARS-CoV-2 Rapid IgM-IgG combined antibody tests on capillary whole blood samples from the fingertip , 2020, PLoS ONE.

[34]  B. Greenhouse,et al.  Are Seroprevalence Estimates for Severe Acute Respiratory Syndrome Coronavirus 2 Biased? , 2020, The Journal of Infectious Diseases.

[35]  E. Crawford,et al.  Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Disproportionately Affects the Latinx Population During Shelter-in-Place in San Francisco , 2020, Clinical Infectious Diseases.

[36]  P. Sullivan,et al.  Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response , 2020, Annals of Epidemiology.

[37]  S. Riley,et al.  Clinical and laboratory evaluation of SARS-CoV-2 lateral flow assays for use in a national COVID-19 seroprevalence survey , 2020, Thorax.

[38]  Brian E. Dixon,et al.  Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random Sample — Indiana, April 25–29, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[39]  Nicholas P. Deputy,et al.  Estimated Community Seroprevalence of SARS-CoV-2 Antibodies — Two Georgia Counties, April 28–May 3, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[40]  P. Sullivan,et al.  Risk for COVID-19 infection and death among Latinos in the United States: examining heterogeneity in transmission dynamics , 2020, Annals of Epidemiology.

[41]  B. Meyer,et al.  SARS-CoV-2 seroprevalence in COVID-19 hotspots , 2020, The Lancet.

[42]  C. Reed,et al.  Seroprevalence of Antibodies to SARS-CoV-2 in Six Sites in the United States, March 23-May 3, 2020 , 2020, medRxiv.

[43]  E. Klein,et al.  SARS-CoV-2 Positivity Rate for Latinos in the Baltimore-Washington, DC Region. , 2020, JAMA.

[44]  A. Flahault,et al.  Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study , 2020, The Lancet.

[45]  Rohit Arora,et al.  SARS-CoV2 Testing: The Limit of Detection Matters , 2020, bioRxiv.

[46]  K. To,et al.  Clinical Performance of the Luminex NxTAG CoV Extended Panel for SARS-CoV-2 Detection in Nasopharyngeal Specimens from COVID-19 Patients in Hong Kong , 2020, Journal of Clinical Microbiology.

[47]  B. Greenhouse,et al.  Are SARS-CoV-2 seroprevalence estimates biased? , 2020, The Journal of infectious diseases.

[48]  C. Sempos,et al.  Adjusting Coronavirus Prevalence Estimates for Laboratory Test Kit Error , 2020, medRxiv.

[49]  Daniel Eichner,et al.  Seroprevalence of SARS-CoV-2-Specific Antibodies Among Adults in Los Angeles County, California, on April 10-11, 2020. , 2020, JAMA.

[50]  Mei San Tang,et al.  Clinical Performance of Two SARS-CoV-2 Serologic Assays , 2020, Clinical chemistry.

[51]  Jacob E. Sunshine,et al.  Occurrence and Timing of Subsequent SARS-CoV-2 RT-PCR Positivity Among Initially Negative Patients , 2020, medRxiv.

[52]  David R. Holtgrave,et al.  COVID-19 Testing, Epidemic Features, Hospital Outcomes, and Household Prevalence, New York State—March 2020 , 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[53]  J. Duchin,et al.  COVID-19 Outbreak Among Three Affiliated Homeless Service Sites — King County, Washington, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[54]  J. Fuchs,et al.  Assessment of SARS-CoV-2 Infection Prevalence in Homeless Shelters — Four U.S. Cities, March 27–April 15, 2020 , 2020, MMWR. Morbidity and mortality weekly report.

[55]  Gretchen Vogel,et al.  First antibody surveys draw fire for quality, bias. , 2020, Science.

[56]  J. Ioannidis,et al.  COVID-19 antibody seroprevalence in Santa Clara County, California , 2020, medRxiv.

[57]  Kari Stefansson,et al.  Spread of SARS-CoV-2 in the Icelandic Population , 2020, The New England journal of medicine.

[58]  Ryan King,et al.  IDseq—An open source cloud-based pipeline and analysis service for metagenomic pathogen detection and monitoring , 2020, bioRxiv.

[59]  Interim Guidelines for COVID-19 Antibody Testing in Clinical and Public Health Settings , 2020 .

[60]  地理学.  United States Census Bureau , 2011 .

[61]  D. Solís.  US Food and Drug Administration , 2010 .

[62]  David C. Hoaglin,et al.  Practical Considerations in Raking Survey Data , 2009 .

[63]  G. DeFriese,et al.  The New York Times , 2020, Publishing for Libraries.

[64]  A. Winsor.  Sampling techniques. , 2000, Nursing times.

[65]  R. Tibshirani.  Regression Shrinkage and Selection via the Lasso , 1996 .